Quick answer: PHQ-9 scores 0–27 (0–4 minimal, 5–9 mild, 10–14 moderate, 15–19 moderately severe, 20–27 severe) and GAD-7 scores 0–21 (0–4 minimal, 5–9 mild, 10–14 moderate, 15–21 severe). A score ≥10 on either is the validated positive-screen cutoff for major depression or generalized anxiety disorder — it triggers clinical interview, not an automatic diagnosis.
GAD-7 cutoff bands at a glance: 0–4 Minimal — routine care, rescreen annually · 5–9 Mild — watchful waiting, rescreen in 2–4 weeks · 10–14 Moderate — positive screen: clinical interview + treatment plan · 15–21 Severe — active treatment, consider referral. Any score ≥10 is the validated positive-screen cutoff — it triggers clinical intervention and, when documented in the encounter, supports CPT 96127 billing.
Interactive Screening Calculator
PHQ-9 · GAD-7 · PHQ-2 — live scoring, no signup
PHQ-9 — Depression (9 items, 0–27)
1. Little interest or pleasure in doing things
2. Feeling down, depressed, or hopeless
3. Trouble falling or staying asleep, or sleeping too much
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself — or that you are a failure or have let yourself or your family down
7. Trouble concentrating on things
8. Moving or speaking so slowly others noticed, or being so fidgety/restless you have been moving around a lot more than usual
9. Thoughts that you would be better off dead, or of hurting yourself in some way
0/9 answered
GAD-7 — Anxiety (7 items, 0–21)
1. Little interest or pleasure in doing things
2. Feeling down, depressed, or hopeless
3. Trouble falling or staying asleep, or sleeping too much
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself — or that you are a failure or have let yourself or your family down
7. Trouble concentrating on things
0/7 answered
PHQ-9 Total
0/27Suggested ICD-10-CM if criteria met: F32.9/F33.9 · CPT 96127 billable when staff-administered & scored
GAD-7 Total
0/21Suggested ICD-10-CM if criteria met: F41.1 · CPT 96127 billable when staff-administered & scored
Educational tool — not a diagnosis. Results require interpretation by a qualified clinician. This screen does not replace the DSM-5-TR clinical interview.
Why Score Interpretation Gets Searched — and How to Use This Guide
Clinicians search PHQ-9/GAD-7 interpretation for three reasons: they need the severity band for a score in front of them (the MDCalc-style lookup), they need to document what the score means in a note that survives audit, and they need to know what to do next — rescreen, treat, or refer. Spanish-language administration is the fourth driver: with Spanish the second-most-spoken language in US clinical settings, validated Spanish forms and comparable scoring are a daily workflow question.
Use the interactive calculator above for live scoring; use the tables below for the interpretation and documentation layer. The two are designed to work together — score in the calculator, document with the snippets, bill with the CPT rules.
Severity Bands at a Glance
| Score | PHQ-9 (0–27) | GAD-7 (0–21) | Action |
|---|---|---|---|
| Minimal | 0–4 | 0–4 | Routine care; rescreen annually |
| Mild | 5–9 | 5–9 | Watchful waiting; lifestyle measures; rescreen in 2–4 weeks |
| Moderate | 10–14 | 10–14 | Positive screen — clinical interview + treatment |
| Mod. severe / Severe | 15–19 (mod-severe), 20–27 (severe) | 15–21 (severe) | Active treatment — therapy, medication, or both |
The ≥10 Cutoff — What It Actually Means
| Property | PHQ-9 | GAD-7 |
|---|---|---|
| Positive cutoff | ≥10 | ≥10 |
| Sensitivity | ~88% | ~89% |
| Specificity | ~88% | ~82% |
| Validated in | 3,000+ primary care patients (Kroenke 2001) | ~2,740 primary care patients (Spitzer 2006) |
| What it flags | Major depressive disorder | Generalized anxiety disorder (+ any anxiety disorder) |
A positive screen is not a diagnosis. The DSM-5-TR interview establishes criteria — duration, functional impairment, exclusions. Document screen result and interview findings as separate data points.
Combined PHQ-9 + GAD-7 Interpretation
| PHQ-9 | GAD-7 | Interpretation | Typical presentation |
|---|---|---|---|
| ≥10 | ≥10 | Comorbid depression + anxiety | Most common behavioral health presentation; assess both |
| ≥10 | 5–9 | Depression with mild anxiety | Depression-primary treatment pathway |
| 5–9 | ≥10 | Anxiety with mild depression | Anxiety-primary; monitor mood |
| 10–14 | 10–14 | Moderate both | Combined treatment planning |
| <5 | <5 | Neither screen positive | Routine care |
Item 9 — The Suicide Flag
Any PHQ-9 item-9 score ≥1 triggers mandatory suicide risk assessment — regardless of total score. A patient scoring 3 overall with item 9 = 1 still needs the C-SSRS or equivalent triage. Never document "PHQ-9 negative" without checking item 9 separately.
Spanish-Language Administration (PHQ-9 / GAD-7 en Español)
Both instruments have validated Spanish translations with equivalent psychometric properties — scores are comparable across languages. Key notes:
| Consideration | Guidance |
|---|---|
| Validated versions | Use the official Kroenke/Spitzer Spanish translations, not ad-hoc translations |
| Cultural expression | Somatic idioms of distress ("nervios," "dolor de cabeza") may load differently — pair scores with interview |
| Interpreter use | Self-report works better than interpreter-administered; validated Spanish forms preferred |
| Documentation | Record language of administration in the note |
Billing: CPT 96127 for Administration & Scoring
| Rule | Detail |
|---|---|
| Code | CPT 96127 — psychological/neuropsychological test administration + scoring by staff under QHP supervision |
| Time | Per hour of staff time; 16-minute minimum; 1 unit typically covers a screening session |
| Frequency | Most payers: 1 unit per patient per day |
| Same-day E/M | Billable alongside E/M — document separately |
| Documentation | Instrument, date, raw score, severity interpretation, staff time, supervising provider |
| Reimbursement | ~$1–2 per unit (varies by payer) |
Score Change During Treatment — MCID and Response Thresholds
The minimum clinically important difference (MCID) is the score change a patient actually feels:
| Instrument | MCID | What it means |
|---|---|---|
| PHQ-9 | ≥5-point drop | Clinically meaningful improvement — treatment is working |
| GAD-7 | ≥4-point drop | Clinically meaningful improvement |
| PHQ-9 | ≥50% reduction | Response (remission threshold: total ≤4) |
| GAD-7 | ≥50% reduction | Response (remission threshold: total ≤4) |
| Trajectory | Decision |
|---|---|
| ≥MCID drop by week 4–6 | Continue current plan |
| Partial drop | Optimize dose, intensify therapy, or add measurement-based follow-up |
| No change after adequate trial | Switch agent or modality — document the trial and the score that justified the switch |
PHQ-2 and GAD-2 — Primary Care Pre-Screening
The first two items of each instrument form ultra-brief pre-screens for time-constrained visits:
| Pre-screen | Items | Range | Positive threshold | Next step |
|---|---|---|---|---|
| PHQ-2 | Anhedonia + depressed mood | 0–6 | ≥3 | Administer full PHQ-9 |
| GAD-2 | Nervous/on edge + uncontrollable worry | 0–6 | ≥3 | Administer full GAD-7 |
Both trade some sensitivity for speed — appropriate for annual wellness visits and busy intake, not for tracking treatment response.
The PHQ-A Adolescent Variant (Ages 11–17)
The PHQ-A modifies PHQ-9 wording for adolescents with identical 0–27 scoring and severity bands. Two adolescent-specific cautions: irritability may present instead of depressed mood, and item 9 carries elevated weight — adolescent endorsement of item 9 warrants immediate C-SSRS administration and same-visit safety planning.
Measurement-Based Care Protocol
- Baseline — PHQ-9 + GAD-7 at intake (portal or encounter)
- Follow-up — repeat every 2–4 weeks during active treatment
- Interpret — apply MCID thresholds; document score, band, and trajectory
- Decide — continue, optimize, or switch based on the trajectory table above
- Document — the score trail is the medical-necessity record payers audit
Related Resources
- Interactive PHQ-9/GAD-7 calculator — embedded above, live scoring
- PHQ-9 Scoring Guide · GAD-7 Scoring Guide
- Combined PHQ-9 & GAD-7 intake PDF (English & Spanish)
- DSM-5-TR Criteria Quick Reference
- Neuraline screening feature · Psychiatry · Mental health · Pediatrics
Clinical Documentation Snippet
PHQ-9 administered today (past 2 weeks): total 14/27 — moderate depression (positive screen ≥10). GAD-7: 8/21 — mild anxiety (negative screen). PHQ-9 item 9 = 0, no suicide risk flag. Scores consistent with moderate depressive symptoms; clinical interview scheduled to establish DSM-5-TR criteria. Patient prefers Spanish-language forms for future administrations. CPT 96127 billed for staff administration and scoring.
Frequently Asked Questions
Is a PHQ-9 score of 10 automatically a depression diagnosis?
No — it is a positive screen. The ≥10 cutoff identifies patients needing a DSM-5-TR clinical interview; diagnosis additionally requires duration (2-week episode), functional impairment, and exclusion of substance/medical causes. Document the screen and the interview separately.
What does a PHQ-9 score of 15 mean?
15–19 is the moderately severe band — active treatment is indicated (psychotherapy, medication, or both), and suicide-risk assessment is required if item 9 is endorsed. A score of 15 supports medical necessity for structured treatment and higher-complexity E/M documentation.
Can PHQ-9 and GAD-7 be given in Spanish?
Yes — both have validated Spanish translations with equivalent psychometrics; scores are comparable across languages. Use official translations (not ad-hoc), record the language of administration, and pair scores with clinical interview since somatic idioms of distress may load differently.
How often should PHQ-9 be repeated during treatment?
Every 2–4 weeks during active treatment. A ≥5-point drop is the clinically meaningful improvement threshold; a total ≤4 indicates remission. Serial scores are the measurement-based-care record that supports continued treatment authorization.
This guide summarizes PHQ-9 and GAD-7 score interpretation for clinical reference. Screening scores require clinical interpretation — they are not diagnoses.
Score PHQ-9, GAD-7, Y-BOCS, BDI, HAM-D, and MMSE automatically in Neuraline — with AI interpretation and 3-click AI Charting. Explore the screening module or book a demo.
About Neuraline
Neuraline (neura-line.com) is an AI-powered Electronic Health Record (EHR), practice management, and medical billing platform for independent healthcare practices.
